Skip to main content

Table 2 Correlation analysis between IGF2BP3 and markers of immune cells in TIMER

From: Effects of RNA methylation N6-methyladenosine regulators on malignant progression and prognosis of melanoma

Description

Gene markers

SKCM

None

Purity

Cor

P

Cor

P

CD8 + T cell

CD8A

− 0.012

0.794

− 0.016

0.738

CD8B

− 0.022

0.636

− 0.028

0.553

B cell

CD19

− 0.005

0.907

− 0.011

0.810

CD79A

− 0.084

0.068

− 0.086

0.066

T cell (general)

CD3D

− 0.048

0.302

− 0.053

0.254

CD3E

− 0.065

0.158

− 0.069

0.140

CD2

− 0.029

0.523

− 0.035

0.456

Monocyte

CD86

0.094

0.042

0.094

0.044

CD14

0.028

0.547

0.038

0.421

CD115(CSF1R)

0.065

0.162

0.070

0.133

TAM

CCL2

0.063

0.171

0.068

0.146

CD68

0.081

0.078

0.067

0.152

IL10

0.165

 < 0.001

0.167

 < 0.001

M1 Macrophage

INOS(NOS2)

− 0.015

0.743

− 0.009

0.844

IRF5

0.020

0.671

0.027

0.571

COX2(PTGS2)

0.148

0.001

0.151

0.001

CD40

0.019

0.676

0.025

0.594

M2 Macrophage

CD206(MRC1)

0.165

 < 0.001

0.177

 < 0.001

CD163

0.180

 < 0.001

0.189

 < 0.001

VSIG4

0.099

0.031

0.109

0.020

CD200R1

0.147

0.001

0.146

0.002

MS4A4A

0.130

0.005

0.135

0.004

Natural killer cell

KIR3DL1

− 0.055

0.230

− 0.063

0.175

KIR3DL2

− 0.080

0.083

− 0.076

0.104

KIR3DL3

− 0.122

0.008

− 0.125

0.008

KIR2DS4

− 0.122

0.008

− 0.084

0.071

  1. Bold values represent significantly different (P < 0.05)